James M. Frates

Insider Reports History

Entity
Individual
Location
88 Sidney St, Cambridge, MA
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James M. Frates:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Amylyx Pharmaceuticals, Inc. Chief Financial Officer Common Stock 233K $592K $2.53 Sep 12, 2024 Direct
Amylyx Pharmaceuticals, Inc. Chief Financial Officer Common Stock 11.1K $28.1K $2.53 Sep 12, 2024 By Trust
Amylyx Pharmaceuticals, Inc. Chief Financial Officer Stock Option (right to buy) 120K Apr 16, 2024 Direct
Sage Therapeutics, Inc. Director Stock Option (Right to Buy) 12.5K Jun 10, 2024 Direct

Insider Reports Filed by James M. Frates

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AMLX Amylyx Pharmaceuticals, Inc. Sep 12, 2024 1 $101K 4 Sep 16, 2024 Chief Financial Officer
SAGE Sage Therapeutics, Inc. Jun 10, 2024 1 $0 4 Jun 11, 2024 Director
AMLX Amylyx Pharmaceuticals, Inc. Apr 16, 2024 2 $0 4 Apr 18, 2024 Chief Financial Officer
AMLX Amylyx Pharmaceuticals, Inc. Mar 5, 2024 1 -$33.6K 4 Mar 7, 2024 Chief Financial Officer
AMLX Amylyx Pharmaceuticals, Inc. Feb 26, 2024 2 $0 4 Feb 28, 2024 Chief Financial Officer
AMLX Amylyx Pharmaceuticals, Inc. Jan 9, 2024 1 -$44.3K 4 Jan 11, 2024 Chief Financial Officer
SAGE Sage Therapeutics, Inc. Jan 3, 2024 1 $0 4 Jan 4, 2024 Director
AMLX Amylyx Pharmaceuticals, Inc. Oct 31, 2023 1 $0 4 Nov 2, 2023 Chief Financial Officer
AMLX Amylyx Pharmaceuticals, Inc. Aug 23, 2023 2 $125K 4/A Sep 5, 2024 Chief Financial Officer
SAGE Sage Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
AMLX Amylyx Pharmaceuticals, Inc. May 16, 2023 4 -$652K 4 May 18, 2023 Chief Financial Officer
AMLX Amylyx Pharmaceuticals, Inc. Mar 16, 2023 6 -$813K 4/A Mar 24, 2023 Chief Financial Officer
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2023 2 $96.5K 4 Jan 10, 2023 Chief Financial Officer
AMLX Amylyx Pharmaceuticals, Inc. Dec 30, 2022 2 $34.4K 4 Jan 4, 2023 Chief Financial Officer
SAGE Sage Therapeutics, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
AMLX Amylyx Pharmaceuticals, Inc. Feb 11, 2022 1 $0 4 Mar 28, 2022 Chief Financial Officer
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2022 2 $0 4/A Apr 26, 2023 Chief Financial Officer
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2022 0 $0 3/A Apr 26, 2023 Chief Financial Officer
SAGE Sage Therapeutics, Inc. Jun 16, 2021 1 $99.7K 4 Jun 17, 2021 Director
SAGE Sage Therapeutics, Inc. Jun 10, 2021 1 $0 4 Jun 11, 2021 Director